Patients with acute leukemia type m2 can be cured if they can receive active treatment at an early stage. Acute leukemia type m2 belongs to a kind of acute myeloid leukemia, and its bone marrow proliferation is extremely active. With the continuous deepening of the research on acute leukemia and the continuous improvement of the treatment plan, a variety of chemotherapeutic drugs, molecular targeted therapy, etc., the survival of patients can be effectively improved after active treatment. Specific therapeutic drugs include cytarabine, Zoerythromycin and so on. In conclusion, acute leukemia is a malignant tumor of the hematopoietic system. Doctors in the hematology department will conduct a comprehensive assessment based on the patient’s physical status, and make a comprehensive assessment based on the patient’s clinical symptoms, blood tests, bone marrow imaging tests, immune phenotype, etc., and formulate a reasonable treatment plan based on the patient’s condition, and the patient should be actively standardized under the direction of the doctor’s treatment.